|
|||||
|
|
The expression and prognostic significance of bcl‐2‐associated transcription factor 1 in rectal cancer following neoadjuvant therapy |
|
| Authors: | Gordon T Brown Beatriz Cash Ayham Alnabulsi Leslie M Samuel Graeme I Murray |
| Affiliation: | 1. Pathology, Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK;2. Vertebrate Antibodies, Tillydrone Avenue, Aberdeen, UK;3. Department of Clinical Oncology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK |
| Abstract: | |
| Keywords: | bcl‐2‐associated transcription factor 1 biomarker immunohistochemistry monoclonal antibody neoadjuvant therapy prognosis rectal cancer |